KELLIE ROHWER: Open Payments
NPI 1033530266 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,386 in 186 payments from 28 companies in 2025. Trend: 2023 $1,932 · 2024 $4,772 · 2025 $3,386
Food & beverage: $3,386
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $334 |
| Regeneron Healthcare Solutions, Inc. | 13 | $334 |
| GENZYME CORPORATION | 16 | $310 |
| Insmed, Inc. | 15 | $301 |
| AstraZeneca Pharmaceuticals LP | 7 | $272 |
| Axsome Therapeutics, Inc. | 11 | $184 |
| Verona Pharma, Inc. | 14 | $174 |
| Viatris Specialty LLC | 15 | $153 |
| Baxter Healthcare | 7 | $151 |
| HARMONY BIOSCIENCES LLC | 7 | $139 |
Products named: DUPIXENT, Arikayce, NUCALA, Sunosi, AIRSUPRA, Ohtuvayre, YUPELRI, Hillrom - Monarch Airway Clearance System.
Industry payments across OK — which companies pay providers there.
